| BUP-1719532 |
Withanoside IV (15 mg)
Withanoside IV (15 mg) |
[362472-81-9] |
15mg |
咨询客服 |
咨询客服 |
| BUP-1719500 |
Withanolide A (15 mg)
Withanolide A (15 mg) |
[32911-62-9] |
15mg |
咨询客服 |
咨询客服 |
| BUP-1719218 |
White Wax (30 mg)
White Wax (30 mg) |
[8012-89-3] |
30mg |
咨询客服 |
咨询客服 |
| BUP-1719208 |
Whey Protein Method Development Materials (4 x 10 g)
Whey Protein Method Development Materials (4 x 10 g) |
[N/A] |
40mg |
咨询客服 |
咨询客服 |
| BUP-1719102 |
Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one)
Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) |
[15156-56-6] |
50mg |
咨询客服 |
咨询客服 |
| BUP-1719000 |
Warfarin (200 mg)
Warfarin (200 mg) |
[81-81-2] |
200mg |
咨询客服 |
咨询客服 |
| BUP-1718063 |
Voriconazole Related Compound F (50 mg) ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
Voriconazole Related Compound F (50 mg) ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid) |
[5872-08-2] |
50mg |
咨询客服 |
咨询客服 |
| BUP-1718041 |
Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) |
[182369-73-9] |
10mg |
咨询客服 |
咨询客服 |
| BUP-1718039 |
Voriconazole Related Compound C (10 mg) (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone)
Voriconazole Related Compound C (10 mg) (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone) |
[N/A] |
10mg |
咨询客服 |
咨询客服 |
| BUP-1718020 |
Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) |
[137234-63-0] |
10mg |
咨询客服 |
咨询客服 |
| BUP-1718019 |
Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) |
[137330-52-0] |
10mg |
咨询客服 |
咨询客服 |
| BUP-1718008 |
Voriconazole (100 mg)
Voriconazole (100 mg) |
[137234-62-9] |
100mg |
咨询客服 |
咨询客服 |
| BUP-1717708 |
Vitexin (25 mg) ((1S)-1,5-Anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol)
Vitexin (25 mg) ((1S)-1,5-Anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol) |
[3681-93-4] |
25mg |
咨询客服 |
咨询客服 |
| BUP-1457709 |
Vitex negundo Leaf Dry Extract (3 g)
Vitex negundo Leaf Dry Extract (3 g) |
[NA] |
3mg |
咨询客服 |
咨询客服 |
| BUP-1717504 |
Vitamin D Assay System Suitability (1.5 g)
Vitamin D Assay System Suitability (1.5 g) |
[N/A] |
1.5mg |
咨询客服 |
咨询客服 |
| BUP-1714652 |
Vinpocetine Related Compound D (30 mg) (ethyl(12R,13aS,13bS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
Vinpocetine Related Compound D (30 mg) (ethyl(12R,13aS,13bS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) |
[57327-92-1] |
30mg |
咨询客服 |
咨询客服 |
| BUP-1714641 |
Vinpocetine Related Compound C (30 mg) (ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate)
Vinpocetine Related Compound C (30 mg) (ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) |
[N/A] |
30mg |
咨询客服 |
咨询客服 |
| BUP-1714620 |
Vinpocetine Related Compound B (30 mg) (Methyl(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate)
Vinpocetine Related Compound B (30 mg) (Methyl(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) |
[4880-92-6] |
30mg |
咨询客服 |
咨询客服 |
| BUP-1714619 |
Vinpocetine Related Compound A (30 mg) (ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate)
Vinpocetine Related Compound A (30 mg) (ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) |
[40163-56-2] |
30mg |
咨询客服 |
咨询客服 |
| BUP-1714608 |
Vinpocetine (100 mg)
Vinpocetine (100 mg) |
[42971-09-5] |
100mg |
咨询客服 |
咨询客服 |
